Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sexton

Showing results (631-640 of 634) with videos related to

Pageof 64
Sort By:
You have reached the last page of results.This site can display upto 634 results.
European Urology|December 17, 2018
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder CancerF Johannes P van Valenberg, Andrew M Hiar, Ellen Wallace, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of Internal Medicine|February 15, 2019
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trialG L Goll, K K Jørgensen, J Sexton, et al.
Pageof 64

Showing results (631-640 of 634) with videos related to

Sort By:
Pageof 64
You have reached the last page of results.This site can display upto 634 results.
European Urology|December 17, 2018
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder CancerF Johannes P van Valenberg, Andrew M Hiar, Ellen Wallace, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of Internal Medicine|February 15, 2019
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trialG L Goll, K K Jørgensen, J Sexton, et al.
Pageof 64